Johns Hopkins University installation of MILabs VECTor⁺ SPECT/PET Molecular Imaging System

An MILabs VECTor⁺ system had been recently installed at the world-renown Johns Hopkins University, School of Medicine, to further expand their translational molecular imaging research. The VECTor⁺ became Johns Hopkins’ molecular imaging system of choice because of its superior spatial resolution, quantitative accuracy and scanning speed for single-photon emission computerized tomography (SPECT) and positron emission tomography (PET), in addition to its unique capability of true simultaneous SPECT/PET acquisition.

The VECTor⁺ was installed at the Johns Hopkins Molecular Imaging Center / Cancer Functional Imaging Core and will be heavily used to enhance their existing projects, mainly for brain, cardiac cancer and musculoskeletal research as well as for new radiopharmaceuticals development. The research with VECTor+ will be coordinated by Benjamin M. W. Tsui, Ph.D. (Professor of Radiology and Director of the Division of Medical Imaging Physics, Department of Radiology) and Martin G. Pomper, M.D., Ph.D. (Co-Director of the Johns Hopkins Center for Cancer Nanotechnology Excellence).

Johns Hopkins is hosting the In Vivo Preclinical Imaging Workshop on March 11-13, co-hosted by the SNMMI and the University of Virginia. To learn more about the system, please plan your trip to Baltimore to attend this workshop as MILabs will have a significant presence as a “Diamond” sponsor.  The final day of the workshop will include the actual hands-on sessions with the MILabs VECTor⁺ system.  Please register here for the workshop.

Netherlands Cancer Institute to Install MILabs U-SPECT⁺/CT to Enhance Oncology Research

An MILabs U-SPECT⁺/CT system was installed last February at the Netherlands Cancer Institute (NKI) with the mission of enhancing the capabilities of their new central imaging facility and Mouse Clinic. The U-SPECT⁺/CT has been selected as the most suitable system for their research due to its ultra-high spatial resolution, superior speed and sensitivity as well as its multimodal compatibility with other systems.

The research will be led by Dr. Jos Jonkers, the group leader and head of the division of molecular pathology, and Dr. Sven Rottenberg, the group leader in molecular oncology. The system will be used for a broad range of key research projects featuring the development and use of advanced mouse models for cancer, particularly mammary tumorigenesis. The hospital plans for this new facility to be a noval imaging center by making its resources available to other researchers in the academic and pharmaceutical communities in the Netherlands.

Kanazawa University to install MILabs U-SPECT⁺/CT to Expand Molecular Imaging Capabilities

MILabs is pleased to announce that Kanazawa University, a leading university in Japan, will install a MILabs VECTor⁺/CT system to enhance their molecular imaging capabilities at the Advanced Science Research Center. The VECTor⁺/CT has been evaluated to be the most suitable system for their research due to its high performance SPECT and PET capabilities as well as the added benefit of true simultaneous SPECT/PET acquisitions.

The utilization of the system will be coordinated and managed by Professor Seigo Kinuya, who is affiliated with the Institute of Medical, Pharmaceutical and Health Sciences. The system will be used for a broad range of projects in neuroscience and oncology at the center to advance their translational medicine research and the development of novel differential diagnosis techniques.

Sunnybrook Research Institute to install MILabs VECTor⁺

Recently a VECTor+ system was installed at the Sunnybrook Research Institute (SRI), the research workhorse of the Sunnybrook Health Sciences Centre (Toronto, Canada). The system is expected to significantly expand SRI’s molecular imaging capabilities, with its high resolution, superior scanning speed and sensitivity for SPECT and true simultaneous SPECT/PET experiments, contributing to outstanding imaging and quantification results for brain, cardiac, cancer and musculoskeletal applications.

The MILabs VECTor⁺ system is located at the Biomedical Imaging Research Suite, which is housed within the Centre for Research in Image-Guided Therapeutics (CeRIGT). CeRIGT is a unique $160-million center that is bringing medicine from the lab to patients. CeRIGT teams develop and test new ways of diagnosing and treating cancer, heart disease, musculoskeletal disorders, immune deficiencies, stroke, dementia and other neurological conditions. The work at the center covers the entire span of biomedical research – from basic research to clinical trials.

Utilization of the VECTor⁺ will be led by Greg Stanisz, Ph.D.  The system is a great addition to the breadth of equipment at the Biomedical Imaging Research Suite and will contribute to the integration of preclinical and clinical modalities at CeRIGT.

MILabs is very excited to have the opportunity to work with such a prestigious institution and the team of investigators at the Sunnybrook Research Institute, and to see the VECTor⁺ system used in a significant role in supporting the development and advancement of biomedical research in Toronto.